Synapse - Center for Hematologic Malignancies

Results (13553)

miR-29a maintains hematopoietic stem cell self-renewal and is required for myeloid leukemogenesis

Meeting Abstract

Hu, W.; Dooley, J.; Chung, S. S.; Yalcin, S.; Shin, Y. S.; De Strooper, B.; Liston, A.; Park, C. Y.
Blood (2013)

C-terminal-truncating ASXL1 mutations induce MDS via inhibition of PRC2

Meeting Abstract

Inoue, D.; Kitaura, J.; Togami, K.; Nishimura, K.; Enomoto, Y.; Uchida, T.; Kagiyama, Y.; Kawabata, K. C.; Nakahara, F.; Oki, T.; more...
Blood (2013)

Fulltext@MSK | Save

Identification of markers of thrombotic risk and response to cytoreductive intervention In Philadelphia-chromosome negative myeloproliferative neoplams

Meeting Abstract

Hobbs, G. S.; Patel, M.; Chung, Y. R.; Abdel-Wahab, O.; Soff, G. A.; Rampal, R. K.
Blood (2013)

Fulltext@MSK | Save

Mutational profiling of myeloid malignancies for prediction of disease relapse following allogeneic stem cell transplantation

Meeting Abstract

Hanash, A. M.; Devlin, S. M.; Maloy, M.; Knapp, K. M.; Miller, V. A.; Lipson, D.; Stephens, P. J.; Otto, G. A.; Yelensky, R.; Nahas, M. K.; more...
Blood (2013)

Fulltext@MSK | Save

Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute GVHD without increased toxicity in double-unit cord blood transplantation (CBT) recipients

Meeting Abstract

Harnicar, S. J.; Ponce, D. M.; Gregornik, D.; Mathew, S.; Evans, K. L.; Zheng, J.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; more...
Blood (2013)

Fulltext@MSK | Save

Durable responses and improved quality of life with midostaurin (PKC412) in advanced systemic mastocytosis (SM): Updated stage 1 results of the global D2201 trial

Meeting Abstract

Gotlib, J.; Kluin-Nelemans, H. C.; George, T. I.; Akin, C.; Sotlar, K.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Morariu, R.; more...
Blood (2013)

Fulltext@MSK | Save

Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo) substituted for non-liposomal vincristine in CHOP with or without rituximab for patients with untreated aggressive non-Hodgkin's lymphomas

Meeting Abstract

Hagemeister, F. B.; Rodriguez, M. A.; Deitcher, S. R.; Younes, A.; Fayad, L.; Goy, A.; Dang, N. H.; Forman, A.; McLaughlin, P.; Pro, B.; more...
Blood (2013)

Fulltext@MSK | Save

Autologous stem cell transplant is a feasible treatment for older relapsed and refractory Hodgkin lymphoma patients

Meeting Abstract

Glick, H.; Lee, C.; Sauter, C. S.; Moskowitz, C. H.; Matasar, M. J.
Blood (2013)

Fulltext@MSK | Save

Impact of induction regimen and consolidative stem cell transplantation in patients with double hit lymphoma (DHL): A large multicenter retrospective analysis

Meeting Abstract

Gandhi, M.; Petrich, A. M.; Cassaday, R. D.; Press, O. W.; Shah, K.; Whyman, J.; Lansigan, F.; Zelenetz, A. D.; Shah, N.; Fenske, T. S.; more...
Blood (2013)

Fulltext@MSK | Save

Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin

Meeting Abstract

Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
Blood (2013)

Fulltext@MSK | Save